SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today announced that Stephen L. Sabba, M.D., age 49, has been elected to Ligand’s Board of Directors, effective immediately. Dr. Sabba takes the Board seat previously held by Elizabeth M. Greetham, who served as a Director from March 2007 and resigned from the Board, effective July 29, 2008, for personal reasons.
